LYCOS RETRIEVER 
Wyeth: World
built 787 days ago
Wyeth recently applied to WHO for pre-qualification status for PREVNAR. If accepted, this status will enable international agencies to include the vaccine in mass immunization programs in the world's least developed countries. The pre-qualification process is expected to be completed by early 2008.
Source:
MADISON, N.J., January 31, 2005 /PRNewswire-FirstCall/ -- Wyeth today reported results for the 2004 fourth quarter and full year. Worldwide net revenue increased 7% to $4.6 billion for the 2004 fourth quarter and 10% to $17.4 billion for the 2004 full year.
Source:
The rights to combination use for hormone replacement therapy (HRT) with Premarin(R) (conjugated estrogens tablets, USP) the world's leading hormone replacement product marketed by Wyeth-Ayerst for nearly 60 years, are included in the agreement. In addition, Wyeth-Ayerst will take full responsibility for development and marketing of combinations of trimegestone with 17 beta estradiol for hormone replacement therapy.
Source:
The World Health Organization initiated the Global Smallpox Eradication Program in 1967, and approached Wyeth to develop a better injection system for smallpox vaccines which could be used in the field. Wyeth waived patent royalties on its innovative bifurcated needle, aiding in the delivery of over 200 million smallpox vaccines per year.
Source:
MORE ABOUT
World